Gastric Electric Stimulator Market

Gastric Electric Stimulator Market Overview (2024 to 2034)

The global gastric electric stimulator market size is estimated to be worth US$ 258.4 million in 2024. The market is expected to progress at a CAGR of 6.5% from 2024 to 2034. The market size is expected to increase over the next decade, reaching a value of US$ 483.6 million by 2034.

The gastric electric stimulator market is expected to witness significant growth during the forecast period due to the rising prevalence of stomach diseases such as gastroparesis, obesity, and gastroesophageal reflux disease (GERD). Moreover, the increasing adoption of minimally invasive surgical procedures and the development of advanced technologies in gastric electric stimulators are further expected to drive the market demand. Additionally, the growing awareness among people regarding the benefits of these devices is also contributing to the market's growth.

The treatment of various stomach disorders such as gastroparesis, obesity, and chronic nausea and vomiting requires gastric electric stimulators, as they work by sending electrical impulses to the stomach muscles, thereby improving motility and reducing the symptoms of these disorders. Advancements in medical technology and the growing awareness about the benefits of these devices are also expected to contribute to the growth of the gastric electric stimulator market. Furthermore, the increasing geriatric population and rising healthcare expenditures are anticipated to boost the demand for gastric electric stimulators.

Report Attributes	Details
Estimated Market Value (2024E)	US$ 258.4 million
Forecasted Market Value (2034F)	US$ 483.6 million
Global Market Growth Rate (2024 to 2034)	6.5% CAGR
High Frequency GES Devices Segment Growth Rate (2024 to 2034)	6.4%CAGR
North America Market Share (2024)	57.2%
East Asia Market Share (2024)	17.0%
Key Companies Profiled	Changzhou Ruishen Medical Equipment Co. Ltd. Chentao Medical Equipment Rishena Co. Ltd. Enterra TM Medtronic Plc. IntraPace Inc. ReShape Lifesciences Inc.

Key Market Growth Drivers

The rising prevalence of gastroparesis is likely to drive sales of gastric electric stimulators over the forecast period. The increasing concerns regarding obesity and gastroparesis are projected to create opportunities for the manufacturers of gastric electric stimulators over the forecast period.

Which Aspects are Increasing the Global Demand for Gastric Electric Stimulators?

“Growing Prevalence of Gastroparesis Across the World”

The growing prevalence of gastroparesis is expected to drive the demand for gastric electric stimulators, which are used to treat the condition. These devices work by delivering electrical impulses to the muscles in the stomach, helping to regulate their movement and improve gastric emptying. They are often used in patients who have not responded to other forms of treatment, such as medication or dietary changes.

Gastroparesis is a medical condition that affects the normal movement of the muscles in the stomach, preventing it from emptying properly. This can lead to a variety of symptoms, such as nausea, vomiting, stomach pain, and bloating. The condition is often caused by nerve damage or other underlying medical conditions such as diabetes, Parkinson's disease, and multiple sclerosis.

“Rising Global Focus on Minimally Invasive Operations”

The gastric electric stimulator market is expected to witness significant growth during the forecast period due to the rising focus on minimally invasive procedures. Gastric electric stimulators are devices that are used to treat obesity and gastroparesis by delivering electrical impulses to the stomach muscles, which can help regulate digestion and appetite.

With a rising number of people suffering from obesity and health-related problems, the demand for minimally invasive weight loss procedures that can help patients lose weight without undergoing major surgery is increasing. Gastric electric stimulators offer a promising alternative to traditional weight loss surgeries, as they are less invasive and can be performed on an outpatient basis.

What is Restraining the Expansion of the Gastric Electric Stimulator Market?

“Increasing Consumer Preferences for Alternative Treatments”

Alternative treatment therapies such as medication or dietary changes are often preferred by patients due to their non-invasive nature and lower cost. This preference for alternative therapies could reduce the demand for gastric electric stimulators, thereby hindering market growth. Additionally, the lack of endorsement from regulatory bodies on the efficacy and safety of the device could also hinder the adoption of gastric electric stimulators. Regulatory approval is crucial for medical devices, and without it patients and healthcare providers may be hesitant to use the device, which could further limit the market growth.

Country-wise Insights

The gastric electric stimulator market finds a significant share of its customer base in North America and Latin America, in line with rising regional sales. North America is expected to hold 57.2% of the global market in 2024. The market in the region is estimated to grow at a moderate CAGR of 6.1% from 2024 to 2034.

East Asia is estimated to account for a share of 17.0% of the market in 2024. East Asia's market is estimated to grow at a 7.3% CAGR during the forecast period, with the region holding 17.4% of the market by the end of the forecast period.

Which Factors Determine the Continued Growth of the United States Gastric Electric Stimulator Market?

“Rising Geriatric Population and Prevalence of Gastroparesis in the United States”

Report Attribute	Detail
Market Value in 2024	US$ 142 million
CAGR (2024 to 2034)	6.1%

The value of the gastric electric stimulators industry in the United States in 2024 is estimated to be US$ 142 million. The market is expected to register a CAGR of 6.1%, reaching a value of US$ 256 million by 2034.

The gastric electrical stimulator market in the United States has been growing steadily over the years due to the increasing prevalence of gastroparesis and other gastrointestinal disorders. Some of the key factors driving the growth of the market include the rising geriatric population, increasing awareness about gastric electrical stimulators, and the development of advanced technologies.

The healthcare infrastructure in the United States is highly advanced, providing patients with access to the latest medical treatments and technologies. Apart from these positive growth factors, the high cost of gastric electrical stimulators and the lack of insurance coverage for these devices, in some cases, remain major challenges for the market.

Why is China Emerging as a Lucrative Market for Gastric Electric Stimulator Suppliers?

“Rising Cases of Gastrointestinal Disorders and Demand for Minimally Invasive Procedures in China”

The gastric electric stimulator market in China has been witnessing steady growth in recent years. This can be attributed to the increasing prevalence of gastrointestinal disorders and the rising demand for minimally invasive procedures. Additionally, advancements in technology have led to the development of more efficient and effective gastric electric stimulators, which has further fueled market growth. The market is expected to continue growing in the coming years, driven by factors such as increasing healthcare expenditure, growing awareness about the benefits of gastric electric stimulators, and a rising geriatric population.

Category-wise Insights

Which Product Type Dominates the Gastric Electric Stimulator Market?

“Increasing Sales of High-frequency GES Devices Augmenting Market Growth”

Attribute	Detail
Market Share in 2024	77.2%

The high-frequency GES devices segment is expected to hold 77.2% of the market by product type in 2024. The CAGR for high-frequency GES devices is expected to be 6.4% through 2034.

High frequency GES devices are designed to help treat gastroparesis, a condition in which the stomach is unable to empty itself properly. These stimulators deliver small electrical impulses to the stomach muscles, which can help improve motility and emptying of the stomach.

One of the key advantages of high-frequency gastric electric stimulators is that they are less invasive than other treatments for gastroparesis, such as surgery.

Competitive Landscape

Major companies are constantly investing in research and development activities to create innovative and effective products. Additionally, there are several small and mid-sized players in the market who are also contributing to the competition. The market is expected to grow significantly over the coming years due to the increasing prevalence of gastrointestinal disorders and rising demand for minimally invasive treatment options.

Some of the prominent companies in the market are Changzhou Ruishen Medical Equipment Co. Ltd., Chentao Medical Equipment, Rishena Co. Ltd., Enterra TM, Medtronic Plc., IntraPace Inc.

Notable Developments

• In 2020, The Enterra II 37800 stomach neurostimulator was introduced by Medtronic plc. It is an implanted, programmable device that generates mild electrical pulses to treat persistent, intractable (medication-resistant) nausea and vomiting caused by gastroparesis.
• In 2021, IntraPace launched the INSPIRIS Control cordless gastric electrical stimulator with patient-centered technology. This wireless technique, which does not require invasive surgery for installation or removal, provides a more practical and patient-friendly option, potentially transforming the stomach electrical stimulation therapy.

Segmentation of Gastric Electric Stimulator Market Research

• By Product Type:

  • High Frequency GES Devices
  • Low Frequency GES Devices

• By Indication Type:

  • Gastroparesis
  • Obesity
  • Refractory Nausea
  • Others

• By End User:

  • Hospitals
  • Outpatients Centers

• By Region:

  • North America
  • Europe
  • Latin America
  • East Asia
  • South Asia & Oceania
  • Middle East & Africa